GRIN2B and autism spectrum disorder: Moreover, a study on autism spectrum disorder shows that repeated OT administration could reduce the transcript expression of N-methyl D-aspartate receptor subtype 2B (NR2B) in the medial prefrontal cortical of C57BL/6 male mouse, compared with a single dose of OT administration [16].